semaglutide approved for mash The FDA has Wegovy (semaglutide) as a treatment metabolic-associated steatohepatitis (MASH) with moderate-to-advanced scarring, a serious liver condition affecting approximately 6% of US adults. Key highlights of drug development program Semaglutide Receives FDA Approval for

Supplementation Supplementing GLP-1 is a key way to reach adequate levels, which can be difficult through diet alone

It was a beautiful day (for SF), I was feeling at peace with myself and my body, and all of a sudden I look over and theres a bus plastered with an ad fo

You never know what seemingly small, but ultimately significant, course of action may make a big difference in the end

Adult males need 90mg per day and adult women should get 75mg per day

Were the trusted partner of hundreds of healthcare practitioners around the country, so you can rely on us when it comes to high-quality medical equipment and more

These medications belong to a class called GLP-1 receptor agonists, originally developed for diabetes management